These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 2408513

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of atracurium, vecuronium and pancuronium on heart rate and arterial pressure in normal individuals.
    Lavery GG, Mirakhur RK, Clarke RS, Gibson FM.
    Eur J Anaesthesiol; 1986 Nov; 3(6):459-67. PubMed ID: 2885185
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
    Hilgenberg JC.
    Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564
    [No Abstract] [Full Text] [Related]

  • 24. [Cisatracurium--is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cistracurium: a comparison with vecuronium].
    Soukup J, Doenicke A, Hoernecke R, qass J.
    Anaesthesist; 1997 Jun; 46(6):486-91. PubMed ID: 9297379
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE, Gratz I, Minassian SS, Hughes DL, Afshar M, Karayannis BN.
    Pharmacotherapy; 1992 Jun; 12(4):278-82. PubMed ID: 1355599
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.
    Foldes FF, Deery A.
    Br J Anaesth; 1983 Jun; 55 Suppl 1():31S-34S. PubMed ID: 6134540
    [Abstract] [Full Text] [Related]

  • 30. Comparison of cutaneous and in vitro histamine release by muscle relaxants.
    North FC, Kettelkamp N, Hirshman CA.
    Anesthesiology; 1987 Apr; 66(4):543-6. PubMed ID: 2436511
    [Abstract] [Full Text] [Related]

  • 31. Tetanic fade following administration of nondepolarizing neuromuscular blocking drugs.
    Gibson FM, Mirakhur RK.
    Anesth Analg; 1989 Jun; 68(6):759-62. PubMed ID: 2567584
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intradermal histamine releasing effect caused by Org-NC 45. A comparison with pancuronium, metocurine and d-tubocurarine.
    Booij LH, Krieg N, Crul JF.
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):393-4. PubMed ID: 6162354
    [Abstract] [Full Text] [Related]

  • 36. A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.
    Montgomery CJ, Steward DJ.
    Can J Anaesth; 1988 Jan; 35(1):36-40. PubMed ID: 2894902
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dose-response relation for atracurium, ORG NC 45 and pancuronium.
    Gramstad L, Lilleaasen P.
    Br J Anaesth; 1982 Jun; 54(6):647-51. PubMed ID: 6123339
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.